| RS2482014062 |
NUS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2482014199 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2482015846 |
NUS1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2482015901 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2482016013 |
NUS1
|
Health Risk |
Likely pathogenic |
Congenital bilateral perisylvian syndrome, Congenital bilateral perisylvian syndrome |
| RS2482016135 |
NUS1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2482016210 |
NUS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2482032088 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2482032232 |
NUS1
|
Health Risk |
Likely pathogenic |
— |
| RS2482032266 |
NUS1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2482037745 |
NUS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 55 |
| RS2482037920 |
NUS1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IAA |
| RS2482042261 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482042289 |
SEC63
|
Health Risk |
Likely pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS2482046323 |
PHIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2482046568 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482054151 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS2482059146 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS2482064962 |
SEC63
|
Health Risk |
Pathogenic |
— |
| RS2482068501 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482077737 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482078362 |
PHIP
|
Health Risk |
Conflicting classifications of pathogenicity |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482078406 |
PHIP
|
Health Risk |
Conflicting classifications of pathogenicity |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482078529 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482082556 |
DSE
|
Health Risk |
Likely pathogenic |
— |
| RS2482086431 |
DSE
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS2482118024 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482118846 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482129454 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482129645 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482129863 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482130041 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482130457 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482131190 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482131205 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482131234 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482131696 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482131715 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482131737 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482134518 |
SIM1
|
Health Risk |
Likely pathogenic |
SIM1-associated metabolic syndrome, SIM1-associated metabolic syndrome |
| RS2482135705 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482136480 |
SIM1
|
Health Risk |
Pathogenic |
— |
| RS2482141216 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482160222 |
JARID2
|
Health Risk |
Likely pathogenic |
Speech apraxia, Stereotypic movement disorder |
| RS2482161504 |
JARID2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2482165302 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482165307 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482171849 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2482181910 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482181938 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482185738 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482185944 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482188475 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482188501 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482189571 |
PHIP
|
Health Risk |
Pathogenic |
— |
| RS2482194191 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482194379 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482194892 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482207163 |
ZNF292
|
Health Risk |
Likely pathogenic |
— |
| RS2482208468 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482210063 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482210497 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482210602 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482216432 |
LMBRD1
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS2482221144 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS2482221339 |
LMBRD1
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2482221622 |
LMBRD1
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS2482237307 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482237317 |
LAMA2
|
Health Risk |
Likely pathogenic |
— |
| RS2482237536 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482237647 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482238214 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482238522 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482241074 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482241440 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482241461 |
OSTM1
|
Health Risk |
Pathogenic |
— |
| RS2482241490 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2482241906 |
OSTM1
|
Health Risk |
Likely pathogenic |
Osteopetrosis, Osteopetrosis |
| RS2482242040 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2482243041 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1B, Maple syrup urine disease type 1B |
| RS2482243158 |
DSE
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS2482251715 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482251798 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482252041 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482252099 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482252172 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482255741 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482258774 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482258800 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482260672 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482267558 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2482268455 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2482268520 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2482269247 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2482270092 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2482274768 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482279719 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482280381 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482284043 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2482284575 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |